98 related articles for article (PubMed ID: 20015645)
1. Novel small molecule bradykinin B1 receptor antagonists. Part 1: benzamides and semicarbazides.
Schaudt M; Locardi E; Zischinsky G; Stragies R; Pfeifer JR; Gibson C; Scharn D; Richter U; Kalkhof H; Dinkel K; Schnatbaum K
Bioorg Med Chem Lett; 2010 Feb; 20(3):1225-8. PubMed ID: 20015645
[TBL] [Abstract][Full Text] [Related]
2. Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivatives.
Schnatbaum K; Schaudt M; Stragies R; Pfeifer JR; Gibson C; Locardi E; Scharn D; Richter U; Kalkhof H; Dinkel K; Zischinsky G
Bioorg Med Chem Lett; 2010 Feb; 20(3):1233-6. PubMed ID: 20036120
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.
Hawkinson JE; Szoke BG; Garofalo AW; Hom DS; Zhang H; Dreyer M; Fukuda JY; Chen L; Samant B; Simmonds S; Zeitz KP; Wadsworth A; Liao A; Chavez RA; Zmolek W; Ruslim L; Bova MP; Holcomb R; Butelman ER; Ko MC; Malmberg AB
J Pharmacol Exp Ther; 2007 Aug; 322(2):619-30. PubMed ID: 17470643
[TBL] [Abstract][Full Text] [Related]
4. Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles.
Zischinsky G; Stragies R; Schaudt M; Pfeifer JR; Gibson C; Locardi E; Scharn D; Richter U; Kalkhof H; Dinkel K; Schnatbaum K
Bioorg Med Chem Lett; 2010 Feb; 20(3):1229-32. PubMed ID: 20015651
[TBL] [Abstract][Full Text] [Related]
5. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.
Liu Q; Qian W; Li A; Biswas K; Chen JJ; Fotsch C; Han N; Yuan C; Arik L; Biddlecome G; Johnson E; Kumar G; Lester-Zeiner D; Ng GY; Hungate RW; Askew BC
Bioorg Med Chem Lett; 2010 Aug; 20(15):4593-7. PubMed ID: 20573508
[TBL] [Abstract][Full Text] [Related]
6. Preparation and optimization of a series of 3-carboxamido-5-phenacylaminopyrazole bradykinin B1 receptor antagonists.
Dressen D; Garofalo AW; Hawkinson J; Hom D; Jagodzinski J; Marugg JL; Neitzel ML; Pleiss MA; Szoke B; Tung JS; Wone DW; Wu J; Zhang H
J Med Chem; 2007 Oct; 50(21):5161-7. PubMed ID: 17880055
[TBL] [Abstract][Full Text] [Related]
7. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
[TBL] [Abstract][Full Text] [Related]
8. Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.
Wood MR; Schirripa KM; Kim JJ; Kuduk SD; Chang RK; Di Marco CN; DiPardo RM; Wan BL; Murphy KL; Ransom RW; Chang RS; Holahan MA; Cook JJ; Lemaire W; Mosser SD; Bednar RA; Tang C; Prueksaritanont T; Wallace AA; Mei Q; Yu J; Bohn DL; Clayton FC; Adarayn ED; Sitko GR; Leonard YM; Freidinger RM; Pettibone DJ; Bock MG
Bioorg Med Chem Lett; 2008 Jan; 18(2):716-20. PubMed ID: 18061443
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
[TBL] [Abstract][Full Text] [Related]
10. Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.
Cole AG; Metzger A; Brescia MR; Qin LY; Appell KC; Brain CT; Hallett A; Ganju P; Denholm AA; Wareing JR; Ritchie TJ; Drake GM; Bevan SJ; MacGloinn A; McBryde A; Patel V; Oakley PJ; Nunez X; Gstach H; Schneider P; Baldwin JJ; Dolle RE; McDonald E; Henderson I
Bioorg Med Chem Lett; 2009 Jan; 19(1):119-22. PubMed ID: 19014884
[TBL] [Abstract][Full Text] [Related]
11. 1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B(1) receptor antagonists.
Guo Q; Chandrasekhar J; Ihle D; Wustrow DJ; Chenard BL; Krause JE; Hutchison A; Alderman D; Cheng C; Cortright D; Broom D; Kershaw MT; Simmermacher-Mayer J; Peng Y; Hodgetts KJ
Bioorg Med Chem Lett; 2008 Sep; 18(18):5027-31. PubMed ID: 18752949
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series.
Kuduk SD; Chang RK; Ng C; Murphy KL; Ransom RW; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
Bioorg Med Chem Lett; 2005 Sep; 15(17):3925-9. PubMed ID: 15993596
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.
Biswas K; Peterkin TA; Bryan MC; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
J Med Chem; 2011 Oct; 54(20):7232-46. PubMed ID: 21902230
[TBL] [Abstract][Full Text] [Related]
14. Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.
Wood MR; Schirripa KM; Kim JJ; Wan BL; Murphy KL; Ransom RW; Chang RS; Tang C; Prueksaritanont T; Detwiler TJ; Hettrick LA; Landis ER; Leonard YM; Krueger JA; Lewis SD; Pettibone DJ; Freidinger RM; Bock MG
J Med Chem; 2006 Feb; 49(4):1231-4. PubMed ID: 16480259
[TBL] [Abstract][Full Text] [Related]
15. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
Su DS; Lim JL; Tinney E; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Yu J; Tang C; Prueksaritanont T; Freidinger RM; Bock MG; Anthony NJ
J Med Chem; 2008 Jul; 51(13):3946-52. PubMed ID: 18553956
[TBL] [Abstract][Full Text] [Related]
16. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
[TBL] [Abstract][Full Text] [Related]
17. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II).
Gao Z; Hurst WJ; Guillot E; Czechtizky W; Lukasczyk U; Nagorny R; Pruniaux MP; Schwink L; Sanchez JA; Stengelin S; Tang L; Winkler I; Hendrix JA; George PG
Bioorg Med Chem Lett; 2013 Jun; 23(11):3421-6. PubMed ID: 23591112
[TBL] [Abstract][Full Text] [Related]
18. Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.
Kuduk SD; Di Marco CN; Chang RK; Wood MR; Schirripa KM; Kim JJ; Wai JM; DiPardo RM; Murphy KL; Ransom RW; Harrell CM; Reiss DR; Holahan MA; Cook J; Hess JF; Sain N; Urban MO; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
J Med Chem; 2007 Jan; 50(2):272-82. PubMed ID: 17228869
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin B1 antagonists: biphenyl SAR studies in the cyclopropanecarboxamide series.
Kuduk SD; DiPardo RM; Chang RK; Di Marco CN; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
Bioorg Med Chem Lett; 2007 Jul; 17(13):3608-12. PubMed ID: 17482459
[TBL] [Abstract][Full Text] [Related]
20. Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonists.
Cole DC; Gross JL; Comery TA; Aschmies S; Hirst WD; Kelley C; Kim JI; Kubek K; Ning X; Platt BJ; Robichaud AJ; Solvibile WR; Stock JR; Tawa G; Williams MJ; Ellingboe JW
Bioorg Med Chem Lett; 2010 Feb; 20(3):1237-40. PubMed ID: 20042333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
